Wagener D J, Geestman E, Borgonjen A, Haanen C
Cancer. 1976 May;37(5):2212-9. doi: 10.1002/1097-0142(197605)37:5<2212::aid-cncr2820370509>3.0.co;2-g.
Cellular immunity was evaluated in 15 untreated patients with Hodgkin's disease before and about 10 days after splenectomy. Skin test-reactivity was not affected by the operation. The number of lymphocytes was moderately increased in patients with pathologic stage I and II disease. The relative proportion of E-binding lymphocytes in the peripheral blood diminished significantly (p = .001) in patients with splenic weights of 240 g and more, whereas the PHA-stimulated thymidine incorporation increased significantly (p = .015) and the proportion of EAC-binding lymphocytes increased significantly (p = .023). The PHA-stimulation of peripheral lymphocytes in patients with pathologic stage I and II disease was at the same level before and after operation, but increased significantly (less than 0.02) in the more disseminated forms. The stimulation of the lymphocytes in vitro by a cocktail of antigens, and by allogeneic cells (MLC) remained unchanged. Although the number of cases studied is rather small, it is concluded that about 10 days after, splenectomy has no demonstrable untoward effect on the cellular immunologic potency.
对15例未经治疗的霍奇金病患者在脾切除术前及术后约10天进行了细胞免疫评估。皮肤试验反应性未受手术影响。病理分期为I期和II期的患者淋巴细胞数量适度增加。脾脏重量达240克及以上的患者外周血中E结合淋巴细胞的相对比例显著降低(p = 0.001),而PHA刺激的胸腺嘧啶核苷掺入显著增加(p = 0.015),EAC结合淋巴细胞的比例显著增加(p = 0.023)。病理分期为I期和II期的患者外周淋巴细胞的PHA刺激在手术前后处于同一水平,但在更广泛播散的类型中显著增加(小于0.02)。抗原混合物和同种异体细胞(混合淋巴细胞培养)对淋巴细胞的体外刺激保持不变。尽管研究的病例数相当少,但得出的结论是,脾切除术后约10天对细胞免疫能力没有明显的不良影响。